International Edition
Latest News
World

Eric Dane Dies at 53: ‘Grey’s Anatomy’ & ‘Euphoria’ Star Loses ALS Battle

Eric Dane, ‘Grey’s Anatomy’ Star, Dies at 53 After Battle with ALS The entertainment world mourns the loss of Eric Dane, the actor celebrated for his roles as Dr. Mark “McSteamy” Sloan on Grey’s Anatomy and Cal Jacobs…

Eric Dane Dies at 53: ‘Grey’s Anatomy’ & ‘Euphoria’ Star Loses ALS Battle

Eric Dane, ‘Grey’s Anatomy’ Star, Dies at 53 After Battle with ALS

The entertainment world mourns the loss of Eric Dane, the actor celebrated for his roles as Dr. Mark “McSteamy” Sloan on Grey’s Anatomy and Cal Jacobs on Euphoria, who passed away on February 19, 2026, at the age of 53. His death followed a courageous, public battle with amyotrophic lateral sclerosis (ALS).

Who Was Eric Dane? A Look Back at the ‘Grey’s Anatomy’ Star

Born in San Francisco in 1972, Eric Dane began his acting career with guest appearances on television shows like Saved by the Bell and Married…With Children. However, it was his role as Dr. Mark Sloan in Grey’s Anatomy in 2006 that propelled him to widespread recognition. His character’s charm and confidence earned him the nickname “McSteamy,” solidifying his status as a pop culture icon. He continued to take on leading roles in series such as The Last Ship and, more recently, delivered a compelling performance as Cal Jacobs in HBO’s Euphoria.

Eric Dane’s Passing: Details of His Death

Eric Dane died on the afternoon of February 19, 2026, surrounded by his wife, Rebecca Gayheart, their two daughters, Billie and Georgia, and close friends, according to a family statement. The cause of death was complications from ALS, a disease he had publicly battled for less than a year. The family expressed gratitude for the outpouring of love and support he received from fans and requested privacy during this challenging time.

Eric Dane’s ALS Diagnosis and Journey

Eric Dane revealed his ALS diagnosis in April 2025. He first noticed weakness in his right hand, initially attributing it to fatigue. Despite the devastating prognosis, he faced his diagnosis with openness and determination. He spoke about his experience, including the rapid loss of function in his limbs, in interviews and at public events.

Timeline: From Diagnosis to Passing

  • April 2025: Eric Dane publicly announces his ALS diagnosis.
  • June 2025: He discusses his initial symptoms and advocates for healthcare reform.
  • September 2025: He is honored with the Advocate of the Year award by the ALS Network and is photographed using a wheelchair.
  • December 2025: Dane announces his memoir, Book of Days.
  • February 19, 2026: Eric Dane passes away at the age of 53.

ALS Advocacy and Awareness Efforts

In his final months, Dane dedicated himself to raising awareness and advocating for research into ALS. He partnered with the nonprofit organization I Am ALS, becoming a vocal advocate for those living with the disease. He emphasized the need for increased funding and visibility for ALS research, stating his desire to “assist” and “be of some service” to others facing the same challenges.

Final Projects and Memoir

Despite his declining health, Eric Dane continued to perform on several projects. He completed scenes for the third season of Euphoria, which is set to premiere on April 12, 2026, and appeared in the Prime Video crime drama Countdown. His final project is his memoir, Book of Days: A Memoir in Moments, published by Maria Shriver’s imprint, The Open Field. In the memoir, he reflects on his life and career, sharing his experiences from the set of Grey’s Anatomy to the birth of his daughters and his journey with ALS. He hoped the book would capture meaningful moments and remind readers “what it means to live with heart.”

About the author: Ibrahim Khalil - World Editor

PhD in International Relations, former UN press officer. Ibrahim has reported from 40+ countries, translating complex geopolitical shifts into clear, human‑focused narratives. “Ibrahim Khalil provides authoritative world news, from diplomacy to conflict zones, with on‑the‑ground insight.”